copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home - Curis, Inc At Curis, we are developing differentiated therapeutics with the goal of improving the lives of cancer patients Our new animation shows how Emavusertib (CA-4948) is being developed to target hematologic malignancies and other cancers
Pipeline Overview - Curis, Inc We are focused on the development and commercialization of innovative therapeutics for the treatment of cancer * IP licensed from Aurigene ** IP licensed to Aurigene *** IP licensed to Genentech Indicates a program included in the Curis intellectual property portfolio, but not currently designated as a priority for clinical development
Emavusertib (CA-4948) - Curis, Inc As part of the collaboration with Aurigene, in October 2015, Curis exclusively licensed a program of orally-available, small molecule inhibitors of IRAK4 kinase, including emavusertib (CA-4948)
Company Overview - Curis, Inc At Curis, we apply this meaning to cancer, by developing novel therapies for slowing or preventing the progression of cancer and prolonging life – or closing and curi͒ng cancer
About - Curis, Inc We are a biotechnology company focused on the development of first-in-class and innovative therapeutics for the treatment of cancer Our clinical stage drug candidates are:
Management - Curis, Inc Maureen E Lane, Ph D » Vice President, Clinical and Translational Science
Open Positions - Curis, Inc We are seeking dedicated, driven, humble, hands-on professionals, from diverse backgrounds, who are passionate about making a difference in the lives of patients and families touched by cancer, and who want to have some fun while doing it
TakeAim Leukemia Clinical Outcomes in AML ASH 2024 - curis. com University Hospital Hamburg Eppendorf, Hamburg, Germany; 15 Nebraska Cancer Specialists, Omaha, NE; 16 Hospital Saint Louis, Paris, France; 17 Emory University, Atlanta, GA; 18 Albert-Schweitzer-Campus 1, Gebäude A1, Münster; 19 Curis Inc , Lexington, MA; 20 University of Texas, MD Anderson Cancer Center, Houston, TX